Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Hypopituitarism risk factors

Introduction

Overview

Overview

Common risk factors in the development of hypopituitarism may include pituitary tumor or space occupying lesion, pituitary apoplexy, severe blood loss such as Sheehan’s syndrome, pituitary surgery, cranial radiation, genetic defects, hypothalamic disease, immunosuppression, inflammatory processes, pituitary infarction, and non-compliance with hormone replacement therapy. Less common risk factors, include infiltrative disorders, traumatic brain injury causing skull fractures, ischemic stroke and subarachnoid hemorrhage.

Risk Factors

Risk Factors

Common risk factors

Common risk factors of hypopituitarism include the following: [1][2][3][4][3][5][6][7][8]

Less common risk factors

Less common risk factors include:

References

References

  1. ↑ Khajeh L, Blijdorp K, Neggers SJ, Ribbers GM, Dippel DW, van Kooten F (2014). “Hypopituitarism after subarachnoid haemorrhage, do we know enough?”. BMC Neurol. 14: 205. doi:10.1186/s12883-014-0205-0. PMCΒ 4207357. PMIDΒ 25312299.
  2. ↑ Vance ML (1994). “Hypopituitarism”. N. Engl. J. Med. 330 (23): 1651–62. doi:10.1056/NEJM199406093302306. PMIDΒ 8043090.
  3. ↑ 3.0 3.1 Jahangiri A, Wagner JR, Han SW, Tran MT, Miller LM, Chen R, Tom MW, Ostling LR, Kunwar S, Blevins L, Aghi MK (2016). “Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis”. J. Neurosurg. 124 (3): 589–95. doi:10.3171/2015.1.JNS141543. PMIDΒ 26252454.
  4. ↑ Snyder PJ, Fowble BF, Schatz NJ, Savino PJ, Gennarelli TA (1986). “Hypopituitarism following radiation therapy of pituitary adenomas”. Am. J. Med. 81 (3): 457–62. PMIDΒ 3092668.
  5. ↑ Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML (1989). “Hypopituitarism following external radiotherapy for pituitary tumours in adults”. Q. J. Med. 70 (262): 145–60. PMIDΒ 2594955.
  6. ↑ Eastman RC, Gorden P, Roth J (1979). “Conventional supervoltage irradiation is an effective treatment for acromegaly”. J. Clin. Endocrinol. Metab. 48 (6): 931–40. doi:10.1210/jcem-48-6-931. PMIDΒ 447799.
  7. ↑ Harbeck B, Klose S, Buchfelder M, Brabant G, Lehnert H (2011). “Hypopituitarism in a HIV affected patient”. Exp. Clin. Endocrinol. Diabetes. 119 (10): 633–5. doi:10.1055/s-0031-1284366. PMIDΒ 21922454.
  8. ↑ Morichika D, Sato-Hisamoto A, Hotta K, Takata K, Iwaki N, Uchida K, Minami D, Kubo T, Tanimoto M, Kiura K (2014). “Fatal Candida septic shock during systemic chemotherapy in lung cancer patient receiving corticosteroid replacement therapy for hypopituitarism: a case report”. Jpn. J. Clin. Oncol. 44 (5): 501–5. doi:10.1093/jjco/hyu019. PMIDΒ 24646812.
  9. ↑ Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, Monson JP, Besser GM, Grossman AB (2000). “Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment”. J. Clin. Endocrinol. Metab. 85 (4): 1370–6. doi:10.1210/jcem.85.4.6501. PMIDΒ 10770168.
  10. ↑ Edwards OM, Clark JD (1986). “Post-traumatic hypopituitarism. Six cases and a review of the literature”. Medicine (Baltimore). 65 (5): 281–90. PMIDΒ 3018425.
  11. ↑ 11.0 11.1 Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK, Ghigo E (2007). “Hypopituitarism”. Lancet. 369 (9571): 1461–70. doi:10.1016/S0140-6736(07)60673-4. PMIDΒ 17467517.
  12. ↑ Benvenga S, CampennΓ­ A, Ruggeri RM, Trimarchi F (2000). “Clinical review 113: Hypopituitarism secondary to head trauma”. J. Clin. Endocrinol. Metab. 85 (4): 1353–61. doi:10.1210/jcem.85.4.6506. PMIDΒ 10770165.
  13. ↑ Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ (2001). “Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury”. J. Clin. Endocrinol. Metab. 86 (6): 2752–6. doi:10.1210/jcem.86.6.7592. PMIDΒ 11397882.
  14. ↑ Agha A, Thornton E, O’Kelly P, Tormey W, Phillips J, Thompson CJ (2004). “Posterior pituitary dysfunction after traumatic brain injury”. J. Clin. Endocrinol. Metab. 89 (12): 5987–92. doi:10.1210/jc.2004-1058. PMIDΒ 15579748.
  15. ↑ Bondanelli M, Ambrosio MR, Carli A, Bergonzoni A, Bertocchi A, Zatelli MC, Ceruti S, Valle D, Basaglia N, degli Uberti EC (2010). “Predictors of pituitary dysfunction in patients surviving ischemic stroke”. J. Clin. Endocrinol. Metab. 95 (10): 4660–8. doi:10.1210/jc.2010-0611. PMIDΒ 20660027.
  16. ↑ Klose M, Brennum J, Poulsgaard L, Kosteljanetz M, Wagner A, Feldt-Rasmussen U (2010). “Hypopituitarism is uncommon after aneurysmal subarachnoid haemorrhage”. Clin. Endocrinol. (Oxf). 73 (1): 95–101. doi:10.1111/j.1365-2265.2010.03791.x. PMIDΒ 20105184.
  17. ↑ Schneider HJ, Kreitschmann-Andermahr I, Ghigo E, Stalla GK, Agha A (2007). “Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review”. JAMA. 298 (12): 1429–38. doi:10.1001/jama.298.12.1429. PMIDΒ 17895459.
  18. ↑ Hannon MJ, Behan LA, O’Brien MM, Tormey W, Javadpour M, Sherlock M, Thompson CJ (2015). “Chronic hypopituitarism is uncommon in survivors of aneurysmal subarachnoid haemorrhage”. Clin. Endocrinol. (Oxf). 82 (1): 115–21. doi:10.1111/cen.12533. PMIDΒ 24965315.

​ ​

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2] Iqra Qamar M.D.[3]